Brief: Quantum Genomics FY operating loss widens at 6.2 million euros
March 30 (Reuters) - Quantum Genomics SA ALQGC.PA :
* Operating result for 2016 was a loss of 6.2 million euros
($6.7 million) versus a loss of 4.3 million euros in 2015
* 2016 net income was 5.2 million euros versus 1.8 million
euros in 2015
* At December 31, 2016, cash was in line with expectations,
amounting to 11.2 million euros compared to 8.7 million euros at
end of 2015
Source text for Eikon: urn:newsml:reuters.com:*:nACT47930
Further company coverage: ALQGC.PA
($1 = 0.9324 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Quantum Genomics SA
See all newsBrief: Quantum Genomics Announces Resumption Of Discussions With HealthTech, Terminates Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics Enters Into Exclusive Negotiations With Vistacare Medical
Brief: Quantum Genomics To Reduce Staff; Jean-Philippe Milon Becomes President and CEO
Brief: Quantum Genomics In Talks For New Strategic Project
Brief: Quantum Genomics Announces Lack Of Significant Efficacy For Firibastat In Their Phase Iii Study